Last reviewed · How we verify

NCT06856915

Effects of Home-based Respiratory Muscle Training Progamme in Individuals With Ischemic Heart Disease

Completed NA Last updated 23 March 2026
What this trial tests

NA trial testing Inspiratory muscle training in Ischemic Heart Disease in 104 participants. Completed in 6 February 2026.

Timeline
1 May 2025
Primary endpoint
6 February 2026
6 February 2026

Quick facts

Lead sponsorUniversidad Complutense de Madrid
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment104
Start date1 May 2025
Primary completion6 February 2026
Estimated completion6 February 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Complutense de Madrid — full company profile →

Who can join

18 and older, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the present study is to verify whether respiratory muscle training programme (IMT+EMT; included both inspriratory and expiratory muscles), applied by telerehabilitation, is an effective intervention (versus placebo and versus inspiratory muscle training in isolation (IMT)) in improving quality of life, cardiopulmonary function and physical and psychological state in people with ischemic heart disease. In addition, the aim is to determine whether respiratory muscle training (IMT or IMT+EMT) is effective in enhancing the results obtained by a conventional cardiac rehabilitation programme on the aforementioned variables.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Inspiratory muscle training

Trials testing the same drug.

Other recruiting trials for Ischemic Heart Disease

Currently open trials in the same condition.

Other Universidad Complutense de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06856915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing